Skip to content

Study · Measured the body's own peptide · 1987

3 results

Modulation of oxytocin secretion by ascending noradrenergic pathways: sexual dimorphism in rats.

Carter DA, Lightman SL

Brain research1 Mar 1987Cited by 10 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Natural levels measured3

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In sham-lesioned rats, acute immobilization stress raised the body's own plasma oxytocin levels, with a significantly greater response in females than in males.

    In plain wordsIn rats, stress raised the body's own oxytocin in blood, more in females than in males.

    Peptide
    Oxytocin
    Outcome
    IncreasePlasma oxytocin after stress in sham-lesioned rats
    Study

    ratn: not reported in source

    male and female rats in acute immobilization stress
    Comparator
    Male compared with female
    Outcome group
    Anxiety and mood · Endocrine and hormones

    Source sentences

    Summary
    In sham-lesioned rats plasma levels of OT were raised following stress, the response being significantly greater in female compared with male animals.
    1 context sentence
    Summary · context
    We have investigated the role of ascending noradrenergic pathways in the control of oxytocin (OT) and arginine-vasopressin (AVP) secretion during acute immobilization stress in male and female rats.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

  2. 02AnimalEndogenous levelAnimal study (in vivo)Other

    In male rats, lesions of the ventral noradrenergic bundle markedly elevated the body's own oxytocin response to stress.

    In plain wordsIn male rats, damaging a brain noradrenaline pathway markedly raised the body's own oxytocin response to stress.

    Peptide
    Oxytocin
    Outcome
    IncreaseOxytocin stress response after VNAB lesion in males
    Study

    ratn: not reported in source

    male and female rats in acute immobilization stress
    Comparator
    Sham-lesioned male rats
    Outcome group
    Anxiety and mood · Endocrine and hormones

    Source sentences

    Summary
    lesioned males exhibited markedly elevated OT stress responses.
    1 context sentence
    Summary · context
    We have investigated the role of ascending noradrenergic pathways in the control of oxytocin (OT) and arginine-vasopressin (AVP) secretion during acute immobilization stress in male and female rats.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

  3. 03AnimalEndogenous levelAnimal study (in vivo)Other

    In female rats, lesions of the ventral noradrenergic bundle did not alter the body's own oxytocin response to stress.

    In plain wordsIn female rats, damaging a brain noradrenaline pathway did not change the body's own oxytocin response to stress.

    Peptide
    Oxytocin
    Outcome
    No significant changeOxytocin stress response after VNAB lesion in females
    Study

    ratn: not reported in source

    male and female rats in acute immobilization stress
    Comparator
    Sham-lesioned female rats
    Outcome group
    Anxiety and mood · Endocrine and hormones

    Source sentences

    Summary
    VNAB lesions were not associated with altered responses in female rats
    1 context sentence
    Summary · context
    We have investigated the role of ascending noradrenergic pathways in the control of oxytocin (OT) and arginine-vasopressin (AVP) secretion during acute immobilization stress in male and female rats.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:53 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.